Although brusatol sensitizes a broad spectrum of cancer cells to antitumor drugs and reduces cell growth13,47, its potent cytotoxic effects appear to act independently of NRF2 inhibition and are more consistent with the profile of a protein translation inhibitor48. Here, NFE2L2 is linked to cancer.